» Articles » PMID: 7263860

Relationship Between Platelet Secretion and Prothrombin Cleavage in Native Whole Blood

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1981 Aug 1
PMID 7263860
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

To determine the relationship between platelet secretion and prothrombin conversion in whole blood, the release of platelet factor 4 and the generation of a X(a)-specific cleavage product of prothrombin, fragment 1 + 2, were measured during the coagulation of whole blood. There was a parallel increase in the concentration of the two proteins. Over the first 5 min of incubation, platelet factor 4 concentration increased 6 ng/ml per min, and after 6-7 min, the rate of release increased to 750 ng/ml per min. Over the initial 5-7 min of incubation, fragment 1 + 2 concentration increased 1.5 pmol/ml per min with a subsequent increase of 45 pmol/ml per min. Incubation with 10 muM prostaglandin E(1) or 15 muM prostaglandin I(2) inhibited secretion of platelet factor 4 and delayed the onset of the rapid phase of fragment 1 + 2 generation by 8 min, while stimulation of platelet secretion with 1 mug/ml collagen suspension enhanced production of fragment 1 + 2. The addition of either 10 muM epinephrine or 100 ng/ml collagen suspension to whole blood did not affect either platelet factor 4 release or fragment 1 + 2 generation, although the combination of 3 muM epinephrine and 100 ng/ml collagen suspension enhanced platelet release and prothrombin cleavage. The relationship between platelet factor 4 release and prothrombin cleavage was also studied in Factor VIII-deficient blood. When 0.001 U/ml factor VIII activity was present, <80 ng/ml platelet factor 4 were released, and no fragment 1 + 2 was generated after 30 min of incubation. The addition of 0.008-0.08 U/ml Factor VIII activity progressively increased platelet factor 4 release and prothrombin cleavage. Platelet factor 4 release was normal at 0.08 U/ml Factor VIII activity, whereas prothrombin cleavage was still delayed. Very little thrombin, the amount generated by the cleavage of 3-5 nM fragment 1 + 2, was needed to induce release of platelet factor 4.

Citing Articles

Potential Biomarkers for Early Diagnosis, Evaluation, and Prognosis of Sepsis-Induced Coagulopathy.

Li Y, Li H, Wang Y, Guo J, Zhang D Clin Appl Thromb Hemost. 2023; 29:10760296231195089.

PMID: 37605466 PMC: 10467369. DOI: 10.1177/10760296231195089.


Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19).

Al-Samkari H, Song F, Van Cott E, Kuter D, Rosovsky R Am J Hematol. 2020; 95(12):1479-1485.

PMID: 32780525 PMC: 7436379. DOI: 10.1002/ajh.25962.


Protection of factor Xa from neutralization by the heparin-antithrombin complex.

Teitel J, Rosenberg R J Clin Invest. 1983; 71(5):1383-91.

PMID: 6222069 PMC: 437002. DOI: 10.1172/jci110891.

References
1.
Rodbard D . Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin Chem. 1974; 20(10):1255-70. View

2.
PROCTOR R, RAPAPORT S . The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol. 1961; 36:212-9. DOI: 10.1093/ajcp/36.3.212. View

3.
Tollefsen D, Jackson C, MAJERUS P . Binding of the products of prothrombin activation to human platelets. J Clin Invest. 1975; 56(1):241-5. PMC: 436576. DOI: 10.1172/JCI108075. View

4.
Mustard J, Perry D, Kinlough-Rathbone R, Packham M . Factors responsible for ADP-induced release reaction of human platelets. Am J Physiol. 1975; 228(6):1757-65. DOI: 10.1152/ajplegacy.1975.228.6.1757. View

5.
Downing M, Butkowski R, Clark M, Mann K . Human prothrombin activation. J Biol Chem. 1975; 250(23):8897-906. View